" /> Arlocabtagene Autoleucel - CISMeF





Preferred Label : Arlocabtagene Autoleucel;

NCIt synonyms : Autologous Anti-GPRC5D CAR-T Cells CC-95266; Autologous Anti-GPRC5D CAR T-cells BMS-986393; GPRC5D-targeted Autologous CAR T Cells BMS-986393;

NCIt definition : A preparation of autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) human G-protein coupled receptor family C group 5 member D (GPRC5D), with potential immunostimulating and antineoplastic activities. Upon leukapheresis, isolation, transduction, expansion ex vivo, and reintroduction into the patient, arlocabtagene autoleucel specifically recognizes and induces selective toxicity in GPRC5D-expressing tumor cells. GPRC5D is overexpressed in certain malignancies, such as multiple myeloma, while minimally expressed in normal, healthy cells. It plays a key role in tumor cell proliferation.;

UNII : WQ79GLJ8VP;

Molecule name : BMS 986393; CC-95266; CC 95266; BMS-986393;

NCI Metathesaurus CUI : CL1922178;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
03/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.